Sickle Cell Disease: Targeting Alloantibody Formation Reduction; Risk Factors, and Genetics
Clinical trial NCT03288012 · UNKNOWN
Trial details
- NCT number
- NCT03288012
- Sponsor
- Sanquin Research & Blood Bank Divisions
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2017-09-20
- Primary completion
- 2021-06-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.